Focused ultrasound spleen stimulation for septic shock in adults
Official title: Effects of Focused Ultrasound Spleen Neuromodulation on Inflammatory Cytokine Levels in Patients With Septic Shock: A Randomized Controlled Pilot Trial
Run by First Affiliated Hospital of Wannan Medical College · NCT06990295 · Data updated 2026-11-12
This trial tests whether non-invasive ultrasound aimed at the spleen can help reduce inflammation in adults with septic shock.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | First Affiliated Hospital of Wannan Medical College Academic / other |
| Locations | 1 site (Wuhu, Anhui) |
| Status | Recruiting |
| Started | July 25, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | May 19, 2026 |
| Trial ID | NCT06990295 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years or older with septic shock admitted to the ICU within 24 hours and expected to need intensive care for at least 72 hours.
✕Probably not a fit
Patients without a response to the intervention or with contraindications to ultrasound splenic treatment may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In this randomized pilot study, adults with septic shock receive either standard care or standard care plus twice-daily, non-invasive focused ultrasound to the spleen for five days. The goal is to see if spleen neuromodulation lowers inflammatory cytokines and influences organ function. Researchers will measure cytokine levels (TNF-α, IL-1β, IL-6, IL-10), lymphocyte subpopulations, SOFA scores, ICU stay, and 28-day mortality, while monitoring safety. The study uses a portable device to deliver targeted energy to the splenic region in the intervention arm. Outcomes will help determine if this approach is a safe and potentially effective immunomodulatory therapy for septic shock.
Why it matters
Potential benefit: If successful, patients could experience reduced inflammation and better organ function, potentially improving recovery in septic shock.
How similar studies have gone: Previous approaches targeting immune modulation in septic shock have shown mixed results; this is a novel, early-stage pilot evaluating spleen-focused ultrasound.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years, regardless of sex * Diagnosed with septic shock according to Sepsis-3 criteria: Sequential Organ Failure Assessment (SOFA) score ≥ 2 and requiring vasopressor support to maintain a mean arterial pressure (MAP) ≥ 65 mmHg. * Admitted to the ICU within 24 hours of septic shock diagnosis * Expected to require intensive care for at least 72 hours * Informed consent obtained from the patient or legal representative Exclusion Criteria: * Known pregnancy or breastfeeding * Participation in another interventional clinical trial within 30 days * Known immunodeficiency or ongoing immunosuppressive therapy * Malignancy with life expectancy \< 6 months * Contraindications to focused ultrasound (e.g., splenic trauma, splenectomy, local skin infection) * Do-not-resuscitate (DNR) order or expected death within 24 hours * Any other condition deemed unsuitable for participation by the investigators
Where it's running
-
The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)
Wuhu, Anhui, China Recruiting
Study contacts
- Study coordinator: Qiancheng Xu
- Email: qianchengxu@wnmc.edu.cn
- Phone: 86-18297529106
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Atrial strain measurement in people with septic shock.
This project tests whether two echocardiography software packages and an AutoStrain tool give similar left and right atrial strain results using past heart ultrasound scans from adults treated for septic shock.
-
Adjunctive Fludrocortisone in Septic Shock on Hydrocortisone
In septic shock, this trial tests whether adding fludrocortisone (50 mcg or 100 mcg daily) to hydrocortisone improves survival and recovery compared with placebo.
-
Computed inspiratory muscle pressure to monitor inspiratory effort during pressure-targeted assist/control ventilation
This study tests a noninvasive computed pressure method (cPmus) to see if it matches the traditional esophageal pressure method for measuring inspiratory effort in adults on pressure-targeted ventilation with spontaneous breathing.
-
Noninvasive estimate of inspiratory effort to monitor pressure support ventilation
This study tests whether a noninvasive computed inspiratory muscle pressure (cPmus) can match the traditional esophageal pressure method for adults on pressure support ventilation.
-
Non-invasive hemodynamic guidance for sepsis care on medical wards
This trial tests whether guiding fluid and vasopressor therapy for sepsis using non-invasive hemodynamic measurements works better than standard care.
-
Reducing Endotoxin Burden in Septic Shock Patients on CRRT with the oXiris Filter
This trial tests whether using the oXiris hemofilter during continuous kidney replacement helps lower endotoxin levels in adults with septic shock who need CRRT.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.